We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Tysabri Withdrawal Prompts Layoffs at Biogen Idec
Tysabri Withdrawal Prompts Layoffs at Biogen Idec
September 16, 2005
Biogen Idec recently announced it will lay off 650 employees following the decision last winter to voluntarily withdraw its once promising multiple sclerosis drug Tysabri.